BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34642055)

  • 1. Analysis of the risk factors for central lymph-node metastasis of cN0 papillary thyroid microcarcinoma: A retrospective study.
    Liu J; Fan XF; Yang M; Huang LP
    Asian J Surg; 2022 Aug; 45(8):1525-1529. PubMed ID: 34642055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.
    Lin Y; Cui N; Li F; Wang Y; Wang B
    Front Endocrinol (Lausanne); 2024; 15():1330896. PubMed ID: 38745958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.
    Wang Z; Gui Z; Wang Z; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Shi J; Wu P; Ji X; Zhang H; Sun W
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):609-621. PubMed ID: 36263602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.
    Qiu P; Guo Q; Pan K; Lin J
    BMC Cancer; 2024 Feb; 24(1):235. PubMed ID: 38378515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
    Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
    J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nomogram Based on Clinicopathological and Ultrasound Imaging Characteristics for Predicting Cervical Lymph Node Metastasis in cN0 Unilateral Papillary Thyroid Microcarcinoma.
    Zhang L; Ling Y; Zhao Y; Li K; Zhao J; Kang H
    Front Surg; 2021; 8():742328. PubMed ID: 34926565
    [No Abstract]   [Full Text] [Related]  

  • 8. Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
    Sun J; Jiang Q; Wang X; Liu W; Wang X
    Front Endocrinol (Lausanne); 2021; 12():613974. PubMed ID: 33868164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
    Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
    Wang ZH; Zhang YJ; Fu GM; Chen YB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk Factors for Nodal Metastasis in cN0 Papillary Thyroid Microcarcinoma.
    Zhang LY; Liu ZW; Liu YW; Gao WS; Zheng CJ
    Asian Pac J Cancer Prev; 2015; 16(8):3361-3. PubMed ID: 25921145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.
    Liu LS; Liang J; Li JH; Liu X; Jiang L; Long JX; Jiang YM; Wei ZX
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1327-1338. PubMed ID: 27645473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.
    Wen X; Jin Q; Cen X; Qiu M; Wu Z
    World J Surg Oncol; 2022 Apr; 20(1):106. PubMed ID: 35365171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of central lymph node dissection for papillary thyroid carcinoma in cN0 T1/T2].
    Zhao SY; Ma YH; Yin Z; Zhan XX; Cheng RC; Qian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):105-109. PubMed ID: 29429179
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlation analysis of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and central cervical lymph node metastasis of papillary thyroid microcarcinoma].
    Song CY; Meng YL; Liu B; Yan L; Shang PZ; Jia ZF; Jiang YB; Meng FY
    Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):944-948. PubMed ID: 34530577
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.
    Qu N; Zhang L; Ji QH; Chen JY; Zhu YX; Cao YM; Shen Q
    World J Surg; 2015 Oct; 39(10):2459-70. PubMed ID: 26099728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Web-Based Ultrasonic Nomogram Predicts Preoperative Central Lymph Node Metastasis of cN0 Papillary Thyroid Microcarcinoma.
    Huang C; Cong S; Shang S; Wang M; Zheng H; Wu S; An X; Liang Z; Zhang B
    Front Endocrinol (Lausanne); 2021; 12():734900. PubMed ID: 34557165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
    Zhang Q; Wang Z; Meng X; Duh QY; Chen G
    Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
    Gui CY; Qiu SL; Peng ZH; Wang M
    J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariable model of BRAF
    Chen BD; Zhang Z; Wang KK; Shang MY; Zhao SS; Ding WB; Du R; Yu Z; Xu XM
    Cancer Manag Res; 2019; 11():7211-7217. PubMed ID: 31440100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.